A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Conditions: Carcinoma, Non-small-Cell Lung Interventions: Drug: JNJ-86974680; Drug: Cetrelimab; Radiation: Radiation Therapy Sponsors: Johnson& Johnson Enterprise Innovation Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Lung Cancer | Non-Small Cell Lung Cancer | Radiation Therapy | Research | Study